CureVac N.V (CVAC) Social Stream
CUREVAC NV (CVAC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CVAC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 3 | $65 | $41 | $53 | $11.79 | 349.53% |
| 2022-01-05 | 3 | $55 | $41 | $48 | $11.79 | 307.12% |
| 2022-01-18 | 4 | $55 | $41 | $49.333 | $11.79 | 318.43% |
| 2022-04-11 | 4 | $52 | $20 | $37.666 | $11.79 | 219.47% |
| 2022-05-09 | 3 | $52 | $17 | $29.666 | $11.79 | 151.62% |
| 2022-05-27 | 3 | $52 | $17 | $29.333 | $11.79 | 148.8% |
| 2022-08-13 | 3 | $52 | $15 | $28.666 | $11.79 | 143.14% |
| 2022-08-19 | 3 | $52 | $15 | $28.333 | $11.79 | 140.31% |
| 2022-09-17 | 3 | $52 | $13 | $27.666 | $11.79 | 134.66% |
| 2022-11-17 | 3 | $34.001 | $13 | $21.667 | $11.79 | 83.77% |
| 2022-11-18 | 3 | $34.001 | $10 | $19 | $11.79 | 61.15% |
| 2023-01-06 | 3 | $34.001 | $9 | $17.667 | $11.79 | 49.85% |
| 2023-01-27 | 3 | $34.001 | $10 | $21.667 | $11.79 | 83.77% |
The Trend in the Analyst Price Target
Over the past 16 months, CVAC's average price target has gone down $49.71.
Over the past 42 weeks, CVAC's average upside potential has been 126.95%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-11 | 3 | 52.000 | 20 | 37.666 | 17.27 | 118.1% |
| 2022-05-27 | 3 | 52.000 | 17 | 29.333 | 19.35 | 51.59% |
| 2022-09-17 | 3 | 52.000 | 13 | 27.666 | 9.57 | 189.09% |
| 2022-11-21 | 3 | 34.001 | 9 | 17.667 | 7.95 | 122.23% |
| 2023-01-04 | 3 | 34.001 | 9 | 17.667 | 6.58 | 168.5% |
CVAC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 35 weeks, CVAC's average broker recommendation rating improved by 0.67.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, CUREVAC NV's number of analysts covering the stock is higher than 154.11% of them.
- In terms of how CUREVAC NV fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 1375.2% of that group.
- To contextualize these metrics, consider that out of stocks in the large market cap category, CUREVAC NV's variance in analysts' estimates is lower than -1031.32% of them.
- In terms of how CUREVAC NV fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 267.26% of that group.
Stocks similar to CUREVAC NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MRVI, ABCL, and RVMD.
View All Top Stocks by Price Target
Is CVAC a Buy, Hold or Sell? See the POWR Ratings now!